孕妇和哺乳期妇女：HIV病毒载量监测的重点人群。
Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.
作者信息
Myer Landon, Essajee Shaffiq, Broyles Laura N, Watts D Heather, Lesosky Maia, El-Sadr Wafaa M, Abrams Elaine J
机构信息
Division of Epidemiology & Biostatistics, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
Centre for Infectious Diseases Epidemiology & Research, School of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa.
出版信息
PLoS Med. 2017 Aug 15;14(8):e1002375. doi: 10.1371/journal.pmed.1002375. eCollection 2017 Aug.
Abstract
Landon Myer and colleagues discuss viral load monitoring for pregnant HIV-positive women and those breastfeeding; ART treatments can suppress viral load and are key to preventing transmission to the child.
摘要
兰登·迈尔及其同事讨论了对感染艾滋病毒的孕妇和哺乳期妇女进行病毒载量监测的问题；抗逆转录病毒疗法可以抑制病毒载量，是防止病毒传播给儿童的关键。
相似文献
1
Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.
PLoS Med. 2017 Aug 15;14(8):e1002375. doi: 10.1371/journal.pmed.1002375. eCollection 2017 Aug.
2
Anti-retroviral therapy failure in HIV-1 infected pregnant women and its associated risk of HIV transmission.
Arch Gynecol Obstet. 2020 Nov;302(5):1229-1235. doi: 10.1007/s00404-020-05743-8. Epub 2020 Aug 14.
3
Antiretroviral drugs to prevent mother-to-child transmission of HIV during breastfeeding.
Curr HIV Res. 2013 Mar;11(2):102-25. doi: 10.2174/1570162x11311020004.
4
Limited risk of drug resistance after discontinuation of antiretroviral prophylaxis for the prevention of breastfeeding transmission of HIV.
J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):301-4. doi: 10.1097/QAI.0b013e318220ed92.
5
[Breastfeeding for HIV-positive mothers in Switzerland : are we ready to discuss ?].
Rev Med Suisse. 2020 Oct 28;16(712):2050-2054.
6
Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa.
AIDS. 2020 Feb 1;34(2):311-315. doi: 10.1097/QAD.0000000000002400.
7
HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study.
J Int AIDS Soc. 2019 Sep;22(9):e25376. doi: 10.1002/jia2.25376.
8
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Clin Infect Dis. 2023 Feb 8;76(3):e590-e598. doi: 10.1093/cid/ciac703.
9
Breastfeeding and HIV-1 infection. A review of current literature.
Adv Exp Med Biol. 2000;478:201-10. doi: 10.1007/0-306-46830-1_18.
10
HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.
PLoS Med. 2011 Mar;8(3):e1000430. doi: 10.1371/journal.pmed.1000430. Epub 2011 Mar 29.
引用本文的文献
1
Cost and clinical flow of point-of-care urine tenofovir testing for treatment monitoring among people living with HIV initiating ART in South Africa.
J Int AIDS Soc. 2025 Jul;28(7):e70004. doi: 10.1002/jia2.70004.
2
Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya.
AIDS. 2025 Jul 15;39(9):1273-1282. doi: 10.1097/QAD.0000000000004207. Epub 2025 Apr 9.
3
Determinants of HIV viral load suppression rates in Amhara region, Ethiopia with a large number of internally displaced people.
J Migr Health. 2025 Feb 11;11:100304. doi: 10.1016/j.jmh.2025.100304. eCollection 2025.
4
Role of Dolutegravir-based antiretroviral treatment in achieving an undetectable HIV-1 viral load among women attending prevention of mother-to-child transmission clinics in Addis Ababa, Ethiopia.
SAGE Open Med. 2025 Feb 12;13:20503121251320460. doi: 10.1177/20503121251320460. eCollection 2025.
5
"I desire to have an HIV-free baby": pregnant and breastfeeding mothers' perceptions of Viral load testing and suppression in HIV care in southwestern Uganda.
Discov Soc Sci Health. 2024;4(1):60. doi: 10.1007/s44155-024-00120-1. Epub 2024 Nov 6.
6
Viral load non-suppression status among women exposed to Dolutegravir-based versus Efavirenz-based regimens in Ethiopia: A before-and-after study.
PLoS One. 2024 Jun 10;19(6):e0305331. doi: 10.1371/journal.pone.0305331. eCollection 2024.
7
Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study.
HIV AIDS (Auckl). 2024 May 13;16:203-215. doi: 10.2147/HIV.S456261. eCollection 2024.
8
Retrospective review of maternal HIV viral load electronic gatekeeping codes in South Africa.
South Afr J HIV Med. 2024 Feb 20;25(1):1539. doi: 10.4102/sajhivmed.v25i1.1539. eCollection 2024.
9
Understanding mother-to-child transmission of HIV among mothers engaged in HIV care in Kenya: a case report.
Int Breastfeed J. 2024 Feb 24;19(1):14. doi: 10.1186/s13006-024-00622-3.
10
Compliance to Viral Load Monitoring Schedules Among Women Attending Prevention of Vertical HIV Transmission Services Before and During the COVID-19 Pandemic in Ehlanzeni District, Mpumalanga, South Africa.
AIDS Behav. 2024 Mar;28(3):868-885. doi: 10.1007/s10461-023-04192-z. Epub 2023 Oct 13.
本文引用的文献
1
Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
PLoS One. 2016 Dec 22;11(12):e0168671. doi: 10.1371/journal.pone.0168671. eCollection 2016.
2
Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Clin Infect Dis. 2017 Feb 15;64(4):422-427. doi: 10.1093/cid/ciw792.
3
Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):279-284. doi: 10.1097/QAI.0000000000001228.
4
Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program.
Clin Infect Dis. 2016 Nov 1;63(9):1227-1235. doi: 10.1093/cid/ciw500. Epub 2016 Jul 26.
5
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18.
6
Reducing mortality in HIV-infected infants and achieving the 90-90-90 target through innovative diagnosis approaches.
J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20299. doi: 10.7448/IAS.18.7.20299. eCollection 2015.
7
Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
Nature. 2015 Dec 3;528(7580):S68-76. doi: 10.1038/nature16046.
8
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods.
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):399-406. doi: 10.1097/QAI.0000000000000874.
9
The impacts of maternal mortality and cause of death on children's risk of dying in rural South Africa: evidence from a population based surveillance study (1992-2013).
Reprod Health. 2015 May 6;12 Suppl 1(Suppl 1):S7. doi: 10.1186/1742-4755-12-S1-S7.
10
HIV infection: epidemiology, pathogenesis, treatment, and prevention.
Lancet. 2014 Jul 19;384(9939):258-71. doi: 10.1016/S0140-6736(14)60164-1. Epub 2014 Jun 5.
Zotero 插件